Table 2.
Causative Candida species and source of infection
| Variables | Total cohort (n = 68) | 30-day survivors (n = 31) | 30-day non-survivors (n = 37) | P value |
|---|---|---|---|---|
| Causative Candida species* | ||||
| Candida albicans | 40 (58.8) | 19 (61.3) | 21 (56.8) | 0.806 |
| Candida glabrata | 17 (25.0) | 6 (19.4) | 11 (29.7) | 0.405 |
| Candida parapsilosis | 8 (11.8) | 3 (9.7) | 5 (13.5) | 0.719 |
| Candida tropicalis | 7 (10.3) | 3 (9.7) | 4 (10.8) | 1.000 |
| Candida krusei | 1 (1.5) | 1 (3.2) | 0 (0.0) | 0.456 |
| Others | 1 (1.5) | 0 (0.0) | 1 (2.7) | 1.000 |
| Source of infection | ||||
| CVC-related | 30 (44.1) | 15 (48.4) | 15 (40.5) | 0.625 |
| Intra-abdominal | 10 (14.7) | 4 (12.9) | 6 (16.2) | 0.745 |
| Skin and soft tissue | 4 (5.9) | 3 (9.7) | 1 (2.7) | 0.324 |
| Cardiovascular | 1 (1.5) | 0 (0.0) | 1 (2.7) | 1.000 |
| Others or unknown | 23 (33.8) | 9 (29.0) | 14 (27.8) | 0.607 |
Values are given as n (%). CVC central venous catheter
*Two causative Candida species were isolated simultaneously in 6 (8.8%) patients